Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of creatine phosphate sodium injection in children with infective myocarditis
ChiCTR-OPC-17014034Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of phosphocreatine in arrhythmogenic cardiomyopathy (ACM) (3 cohorts), sponsored by Beijing Children's Hospital. Primary endpoints: Electrocardiogram, Myocardial enzymes and 1 more. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
phosphocreatine
03
Conditions
arrhythmogenic cardiomyopathy (ACM)
Beyond the preview
Go deeper on ChiCTR-OPC-17014034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17014034.